Grenzach-Wyhlen, Germany

Sabine Gruener


 

Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Sabine Gruener in Ophthalmology

Introduction: Sabine Gruener is a prominent inventor based in Grenzach-Wyhlen, Germany, known for her significant contributions to the field of ophthalmology. With a portfolio of four patents, her work primarily focuses on bispecific antibodies and their applications in medical treatments.

Latest Patents: Sabine's latest patents include groundbreaking research on bispecific antibodies designed to bind specifically to two distinct antigens. These antigens include human ANG2, human VEGF, human IL-1beta, and human PDGF-B. Additionally, she has developed humanized anti-IL-1beta antibodies that are variants of the murine anti-IL-1beta antibody H34. One such humanized antibody comprises unique hypervariable regions, specifically HVR-H1, HVR-H2, and HVR-H3, that feature distinct amino acid sequences, allowing for targeted therapeutic applications.

Career Highlights: Sabine Gruener currently works at Hoffmann-La Roche Inc., where she continues to innovate and push the boundaries of scientific research in the field. Her dedication to developing novel therapeutic antibodies marks her as a key figure in advancing treatment methodologies in ophthalmology.

Collaborations: Throughout her career, Sabine has collaborated with esteemed colleagues like Stefan Dengl and Peter Michael Huelsmann. These collaborations have further reinforced her position as a leading inventor in biotechnology and therapeutics.

Conclusion: Sabine Gruener's inventiveness and commitment to ophthalmological advancements are evident through her impressive patent portfolio. Her innovative research continues to make a notable impact on the medical community, promising improvements in treatment outcomes for various eye-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…